Loading summary
Transcript134 lines
- [00:01]
Deloitte Narrator
The right technology can strengthen human judgment. That's why Deloitte brings together AI and data analytics with multidisciplinary teams who can help you connect the dots across your enterprise, from risk to operations to customer needs. So opportunities don't slip by and surprises don't spread. Because the smarter your systems, the sharper your instincts. That's how technology makes people better at what they do best. Deloitte Together makes progress. Learn more@deloitte.com TogetherMakesProgress okay, before we get
- [00:35]
Public Ad Representative
into it, little side note for the
- [00:37]
IBM Representative
IT leaders listening in.
- [00:38]
Public Ad Representative
I was reading up on a Microsoft Commission survey the other day and learned that teams using Windows 11 Pro PCs report 62% fewer security incidents compared to Windows 10 PCs, including three times fewer firmware attacks. Pretty significant. With security built in, you'll have AI ready it. That sets you up for operational efficiency
- [01:01]
IBM Representative
as well as long term resilience.
- [01:03]
Public Ad Representative
Upgrade to Windows 11 Pro@WindowsMeansBusiness.com if you
- [01:08]
Cincinnati Insurance Narrator
follow markets, you know the value of long term thinking. You plan, you diversify, you prepare for volatility. But even the best strategies can't prevent every bad day. For more than 75 years, Cincinnati Insurance has helped individuals and businesses navigate tough moments. With expertise, personal attention and independent agents who focus on relationships, not transactions, the Cincinnati insurance companies let them make your bad day better. Find an agent@cin fin.com Bloomberg Audio Studios podcasts Radio News.
- [01:54]
Caroline Hyde
Bloomberg Tech is live from coast to coast with Caroline Hyde in New York
- [01:59]
Cincinnati Insurance Narrator
and Ed Ludlow in San Francisco.
- [02:04]
Ed Ludlow
This is Bloomberg Tech. Coming up, all eyes are on a high stakes meeting between President Trump and China Xi Jinping. This is Nvidia CEO Jensen Huang gets added to the trip last minute plus
- [02:15]
Caroline Hyde
Anthropic is looking to raise at least $30 billion in fresh financing and a valuation of more than $900 billion. What could be its largest funding round yet.
- [02:24]
Ed Ludlow
And we speak with Anduril CEO Brian Schimpf as the company hits a $61 billion val. Latest funding round today's big story. President Trump's meeting with China's Xi Jinping. And Trump is joined on his trip by a host of tech leaders including in the end, Nvidia CEO Jensen Huang as a last minute addition thrusting air and tech into the spotlight before the high stakes summit. Let's bring in Bloomberg's Tyler Kendall for more who joins us from Beijing. Set the scene. What do we need to know? And my goodness, what a fanfare last night when Jensen Huang was spotted on the Runway in Alaska.
- [03:03]
Tyler Kendall
Right, Ed. I mean, we saw this last minute addition. He caught Air Force One during a refueling stop in Anchorage. Now the White House says that the addition comes because Jensen Huang was able to make a scheduling change. That we did hear from President Trump in a post on Truth Social where he appeared to be unhappy with media coverage that the Nvidia CEO originally wasn't on the manifest of travelers that we had. In terms of those CEOs that are attending now, of course, the big ticket item I don't need to tell either of you would be whether or not President President Trump pushes the Chinese government to have Chinese buyers for the now greenlit H200 Nvidia chips. So maybe there will be some sort of discussions around that. I'll also throw on your radar that it is our understanding that Washington and Beijing are in talks about potential cooperation when it comes to keeping dialogue open around artificial intelligence. That could be also one of those deliverables that we see out of this meeting tomorrow between President Trump and Chinese President Xi Jinping. The administration maintains that they want trade to be the top priority here. Just look at the other list of CEOs. It is our understanding that they represent some of those sectors where we could see some Chinese purchase agreement commitments, including the Cargill CEO when it comes to agriculture and the Boeing CEO also being here on the ground in Beijing. But Ed and Caroline, at this point, it's hard to avoid that Iran will be looming very large over this conversation. In fact, a senior administration official who briefed US reporters before we headed over here to Asia did say that behind closed doors, President Trump is going to push the Chinese president when it comes comes to the country's stance around Iran during this conflict, including how Beijing remains the largest buyer of Iranian crude.
- [04:42]
Caroline Hyde
Bloomberg's Tyler Kendall live in Beijing. We so appreciate it. Thank you. Let's check on the broader markets because it's a volatile trading session. One point, we're in the red on the NASDAQ 100. We're now back in the green. We're up about 6.10of a percent. Leading the pack is of course chip makers once again in terms of points. But I shine a light. What's happening in China. The golden Dragon that is the NASDAQ Golden Dragon index, which is really basically the trading of Chinese names here in the US the ADRs were up 3 1/2 percent. There is a lot of excitement about what one Jensen one could mean Chinese tech.
- [05:13]
Ed Ludlow
This is really tied to the Nvidia story and Nvidia itself is now up almost 3%. And trading at a record high up for a sixth straight day, matching the run it had in early April. And the story is really simple. A lot of those Chinese AI specific names, Minimax, Jeep, who, the examples we, I mean, look at those gains. That's astonishing overnight on the idea that there might be something here that Tyler
- [05:35]
Caroline Hyde
just outlined something here, something certainly for the market to continue to, to chew on. As we just see relentless exuberant exuberance around. Fiona is in contest with us Citi Index Financial Markets senior analyst and Fiona, is that rationality to the moves in the Chinese names on the back of hope that they'll get access to more powerful chips? Is that something that you're looking to come out of the geopolitical event in China?
- [06:00]
Fiona Senkoto
I mean, it's something we've got our eyes on. So I think, you know, that would be the absolute icing on the cake as far as those stocks are concerned. And that's what we're sort of starting to see priced in in is that optimism that that could potentially be on the table. I mean, the fact that we saw that late edition of Quan John saying, joining the delegation to the US I think has really just sort of been spurred on those hopes. And, and I think this sort of broad, more broadly speaking, I think there is just a level of excitement surrounding Trump's trip to China. And I think that's sort of really evident as we're seeing, you know, the NASDAQ push higher, even though we've got sort concerns regarding inflation and the sort of fundamental backdrop which normally would weigh down the tech index.
- [06:51]
Ed Ludlow
We have been talking about the impact of the latest economic data in the markets, but I want to stay focused on what's happening in China. How does the market interpret and price in this delegation of CEOs that we're showing on the screen right now, Tim Cook, Elon Musk, Chuck Robbins, and as we've all mentioned, Jensen Huang with the president. What is it the market thinks that does?
- [07:16]
Caroline Hyde
This is like the who's who.
- [07:18]
Fiona Senkoto
It's literally the, the top list of the CEOs from the US that you could wish for to go to speak to China regarding trade, regarding, you know, what move forward in a I in chips. I mean, you know, the potential for these two economies to actually get sort of further agreements surrounding such enormous topics would be massive. And I mean, you know, I don't think we can underestimate that. I mean, if we just think about sort of, you know, for example, chips, which, you know, have been a massive part of the Story the rally in recent weeks. You know, if we think about it, the US is, is very much dominating the sort of the AI computing power at the top of the technology stack. But at the bottom you've got China controlling much of the supply chain, critical minerals needed to manufacture semiconductors and advanced electronics. So, you know, if there are these two economies are deeply independent on each other, so the more agreements, the more synergies that they get together, the better that's going to be.
- [08:23]
Caroline Hyde
Look, we are seeing just the run up in semiconductors, hardware in particular continue even if we took a breath yesterday. We're back on and in the green today, Fiona. And it's notable that we're waiting an ipo. It could be price today, likely to start trading tomorrow. And Cerebras. How are you thinking about the appetite among your clients to get more exposure, particularly for these very specific names?
- [08:48]
Fiona Senkoto
Yeah, there's been an extremely ramping up of demand over the last few weeks. I mean, it's definitely caught the markets by surprise. I think, you know, we've seen that rally calm, especially given the fact that we did see sort of a little bit of a more depressed outlook towards these stocks at the end of last year and the beginning of this year. But you know, that has definitely moved forward. We're seeing that our clients are really very interested still in their stocks, which is interesting because I think technically the position is looking a little bit overdone. So I think, you know, there is room for some consolidation, potentially a pullback here. But I think broadly speaking, the, the longer term trend is still looking very positive.
- [09:33]
Ed Ludlow
Yeah, I mean, that's the question for me. What happens next? Right. You know, technology stocks basically are still at record highs, irrespective of what's happening around the world. So what does happen next and why? What is the big swing factor in markets for you?
- [09:47]
Fiona Senkoto
Yeah, completely. I mean, this is what's really interesting is now, I think is the fundamental backdrop that we have is far from ideal. So I think, you know, if we look about what could happen next, I mean, supposing we do get the reopening of the Strait of Hormuz in the, in the coming weeks, that would make the backdrop suddenly much more favorable, which potentially could mean there could be more gains to be had, not just in AI, not just in tech stocks, but potentially across the board. But I think if that doesn't happen, we're still seeing this solid demand for tech. And I think there is a potential, as I said, for it to slow even for there to be some consolidation or a pullback, just given the fact that we are technically so overdone. But I think as far as the chart is looking, there isn't anything on there that's telling us that there are reversals coming anytime soon. And so for the time being, the. The side of least resistance does appear to be upwards.
- [10:42]
Caroline Hyde
And is that global? Fiona, as we're talking about China, we talk about the US But Europe, ASML has been a key name. We think about what's been happening in Japan, in South Korea, which of course was shaken over the last couple of trading days because of talk of maybe some sort of citizen dividend and a sharing of the wealth of AI.
- [11:02]
Fiona Senkoto
Yeah, that's right. I mean, the Cosby, I think, is a really interesting example. We've seen the volatility there really come up. I mean, that had some extremely strong gains before we had that pullback. But I think that's an interesting point that's being made there about the sort of the dividend, the people's dividend on AI, that tax on AI. Is that something that could potentially be a risk point further down the line, more globally? That's something I would be watching out for. But I think for now, this is a global story that we're looking at as far as AI is concerned. And that demand for tech is definitely back on.
- [11:35]
Ed Ludlow
Fiona Senkoto, Citi Index. Great to have you back on Bloomberg Tech. Thank you very much. Coming up, we're going to speak with Anduril CEO Brian Schimpf is the company hits a $61 billion valuation in its latest funding round this next. This is Bloomberg Tech.
- [11:50]
Deloitte Narrator
The right technology can strengthen human judgment. That's why Deloitte brings together AI and data analytics with multidisciplinary teams. People with deep industry experience, experience who can challenge assumptions and help you connect the dots across your enterprise. From risk signals to operational pressure points to shifting customer needs, Deloitte helps you see what's coming sooner so opportunities don't slip by and surprises don't spread. It's not just dashboards. It's real clarity in the moments your decisions are made. When models reveal patterns, people can ask better questions. When data and people are connected, leaders can move faster with confidence. And when your teams are aligned, smart choices can scale from the frontline to the C suite. Because the smarter your systems, the sharper your instincts. That's how technology makes people better at what they do best. Deloitte together makes progress. Learn more@deloitte.com TogetherMakesProgress so there's a lot
- [12:51]
Ed Ludlow
of noise about AI, but time's too tight for more promises.
- [12:54]
IBM Representative
So let's talk about results. At IBM, we work with our employees
- [12:58]
Ed Ludlow
to integrate technology right into the systems they need. Now a Global workforce of 300,000 can use AI to fill their HR questions. Resolving 94% of common questions, not noise
- [13:10]
IBM Representative
Proof of how we can help companies
- [13:12]
Ed Ludlow
get smarter by putting AI where it actually pays off.
- [13:15]
IBM Representative
Deep in the work that moves the business. Let's create smarter business.
- [13:19]
Public Ad Representative
IBM support for the show comes from Public. Public is an investing platform that offers access to stocks, options, bonds and crypto. And they've also integrated AI with tools that can assist investors in building customized portfolios. One of these tools is called generated assets. It allows you to turn your ideas into investable indexes. So let's say you're interested in something specific like biotech companies with high R and D spend, small cap stocks with improving operating margins or the S&P 500 minus high debt companies. Chances are there isn't an ETF that fits your exact criteria. But on public, you just type in a prompt and their AI screens thousands of stocks and builds a one of a kind index. You can even backtest it against the S&P 500. Then you can invest in a few clicks, go to public.com market and earn an uncapped 1% bonus when you transfer your portfolio. That's public.com market ad paid for by Public Holdings Brokerage services by Public Investing Member FINRA, SIPC Advisory Services by Public Advisors SEC Registered Advisor Crypto Services by ZeroHash. Sample prompts are for illustrative purposes only, not investment advice. All investing involves risk of loss. See complete disclosures@public.com Disclosures
- [14:35]
Ed Ludlow
Defence tech startup Anduril has rocketed to a $61 billion valuation after a refreshed $5 billion raise led by Thrive Capital and Andreessen Horowitz. Almost twice the valuation it stood at one year ago. It underscores surging investor appetite for AI driven defense tech. Joining us now is Andrew CEO Brian Schimpf. And Brian, it's good to have you back with us on Bloomberg.
- [14:57]
IBM Representative
You're happy to be here.
- [15:00]
Ed Ludlow
This is confirmation, a little bit of what we reported about a month, couple of months ago. But actually when you come on the program, a lot of the cracks questions we get for you are operational. So let's take the $5 billion that you've raised. How much of that is to get Arsenal One done built and all of the other operational timelines that you guys are holding yourselves to imminently yeah.
- [15:22]
IBM Representative
So as a business, you know, we're entering this period where production is the name of the game. So the vast majority of our capital goes to scaling our factories, building out our production work, workforce, funding all that inventory and really just getting that ramp to production working. We're increasing production revenues something like 250% over the year, just year over year. So just a huge ramp in what we're seeing in terms of demand for our technology.
- [15:48]
Caroline Hyde
Demand, Talk about it, how much breadth are we seeing? The geopolitical conflicts, they have sadly increased and we're still seeing this focus on the need for defense tech. But we know that the money is often still spent on primes.
- [16:02]
IBM Representative
Yeah, I mean, look, we are still relatively young as a company. We're nine years in. We've been very successful by any measure for a company at that age in the defense world. And in, you know, the fraction of the market we're actually addressing right now is still quite small. But where we are seeing a lot of demand is, you know, particularly around things like counter drown and air and missile defense. That's where you look at the current conflict. This is a huge issue. This is a huge area where we're seeing massive increases in what the customers want. You know, our electronic warfare systems, our surface to air missile systems and then the other capability that we're seeing a lot of demand on that was, you know, just announced today was a multi year procurement of a low cost cruise missile that we call Barracuda. The department is buying, you know, thousands a year of these and we're ramping these at just an unprecedented pace and being able to get these out to help with that critical munitions shortage and the ability to sustain these conflicts and provide the deterrence we need.
- [17:02]
Ed Ludlow
Brian, just, just humor me on this 1. The $5 billion is sufficient to finish Arsenal 1 and start the production ramp. Yes.
- [17:10]
IBM Representative
So we are already ramping production with the money we had in the bank. This is really about how do we continue to fuel that growth.
- [17:17]
Natasha Mascarenas
Growth.
- [17:18]
IBM Representative
I don't think we're going to see Arsenal one be done anytime soon. Because I think the demand we're going to continue to see and the amount we're going to have to continue to scale is just going to ramp and ramp over the next several years. This is a good problem to have. Right. And so we benefiting from the private markets and the ability to fund these very aggressive ramps. And it's a huge testament to, you know, the American capital system that we can fund these things very, very quickly.
- [17:44]
Ed Ludlow
It was interesting to Go through a letter to your shareholders. He wrote back in January, actually, and like, kind of foretelling what was to come in the year. There's still a bit of a mystique about Andrew. Right. So I think Palmer, Lucky, one of your co founders, has talked about the idea that half of Andrew's products aren't really known about. There's particular interest in the next wave of subterranean weapons systems. Could you talk as far as you can about where those get built? Built, you know, the next phase of life around the world beyond what the initial focus of Arsenal One is.
- [18:14]
IBM Representative
Yes. So the purpose of the board letter was to lay out a lot of the, you know, kind of why, what are we doing? What's made us successful is we look at, you know, with the shifts in technology, the shifts in warfare, what are the capabilities that are going to be needed over the next five or ten years, and how can we start to invest to bring those forward?
- [18:34]
Mike Shepherd
Forward.
- [18:35]
IBM Representative
So, you know, we're working on a whole plethora of different products, you know, everything expanding the air and missile defense portfolio. We're working on, you know, new domains we're operating in. Palmer's always experimenting with the latest and greatest technologies and figuring out what you can do that nobody thought possible. So we just have a constant source of new ideas how technology can apply. But fundamentally, we look at this question of. Of what are going to be the dominant technologies over the next 10 or 20 years. And what we're seeing in Iran, what we're seeing in Ukraine, is that this idea of just the sheer volume of munitions that are exchanged and the need to defend against that, these are critical capabilities that in any world will need to be solved for. And so a lot of our focus is really around these ideas of, you know, how do we provide the right strike capabilities, the right intelligent targeting capabilities, and the defense of these as well
- [19:34]
Caroline Hyde
at the right price. And I'm really interested, Brian, in some of these new ideas come from the administration itself. And the Golden Dome project is one of those new ideas that, according to current budget forecasts coming from the Congressional Budget Office, could be up to $1.2 trillion of the ultimate project. Now, I know you're among the companies been awarded initial contract expert. What do you make of how much this could end up costing? And it's. And it's worth.
- [20:00]
IBM Representative
So the. A lot of those estimates are based off of what this would have cost historically. Right. And that was based around building these things that are extremely expensive and extremely exquisite where you're talking, you know, 1020, $30 million a shot to, you know, actually provide that defense well, with commercial technologies taking a smarter approach, using a lot of proven capabilities that already exist and adapting them for this problem, we believe you can get this to a much more efficient place and probably even more than the price is, can you even produce it. And today, that's one of the major concerns.
- [20:37]
Ed Ludlow
Right?
- [20:37]
IBM Representative
You know, we. We shot something like a decade of tomahawk production in 72 hours. You know, it's just a crazy rate that we're consuming these things, and the ability to replenish these becomes a critical issue. So our view of this is these are solvable problems. You can do it in a more efficient way than has been historically executed. And I think that, you know, being able to execute this at a national scale is achievable now in a much more aggressive timeline, at a much more efficient price than I think people have historically imagined.
- [21:10]
Ed Ludlow
Okay, you get asked this a lot. Palmer Lucky gets asked this a lot. Trey gets asked it a lot.
- [21:15]
Max Levchin
Lot.
- [21:15]
Ed Ludlow
But when you do a round of this scale and you look at the composition of it, who's not there? People want to know about the rationale for Android going public, why there weren't more crossover investors. You know, this is the first time, actually, Brian, the three of us have had to talk in length because when we were with you in October, the president made some news about China. So just talk us through Brian Shim's thinking on an Andoril ipo.
- [21:41]
IBM Representative
So we want to build one of the most impactful businesses in the world. That's our goal. Right. We want to seriously move the needle for the US and allied warfighters, provide the right deterrence capabilities, and do it at immense scale.
- [21:54]
Ed Ludlow
Right?
- [21:55]
IBM Representative
That is fundamentally what we care about. The rationale for going public is a lot less than it used to be. The private capital markets have grown in scale. The ability to fund a business like ours, you know, when we were doing this a few years ago, we were at the upper end of what capital raises look like in the private market. We are a fraction of an AI fundraise at this point. And so the amount of capital that is available and, you know, wants to support these types of companies is massive. So we're not in a rush to go public. Right. We don't need to do it from the perspective of capital availability or liquidity. You know, we can provide liquidity to our early investors, our employees, in relatively straightforward ways. There's a lot of means to do that. So a lot of the historic reasons of why you rush to go public don't, don't really exist anymore. So for us the question is, when does it actually make sense? And for us it's, you know, we've proven that our business model works, we've proven that we can scale and, you know, the fundamental economics of the business are shown to be, you know, as successful as we want to be. You know, a high growth company that can operate at high margins. That's fundamentally what we want to show. And when we feel like we've shown that that's a perfectly reasonable time to go public. So we're not in any run, we don't have any pressure to do it. It's great.
- [23:14]
Caroline Hyde
Yeah, but investors want a stake, particularly retail. And I know you've been outspoken about the secondary market. Look, today, Anthropic, I think yesterday just put out a new blog saying that. But look, there are some areas in which Anthropic seems to be trading on a secondary market and they call them stocks scams. In some areas they say it's issuing fraudulent share certificates in the private artificial AI developer. Are you warning about that still? How worried are you about Andrew shares trading fraudulently on a secondary market?
- [23:44]
IBM Representative
Look, we try to control our cap table tightly and make sure that, you know, every investor we have, we understand who they are, they're in it for the long haul and they're in it for the right reason. Reasons. The, there is a lot of very bad actors that exist trying to, you know, hawk things that are just not allowed. Right. And we've seen a lot of prosecutions and other things related to this.
- [24:09]
Ed Ludlow
Right.
- [24:09]
IBM Representative
This is not a, a new issue. Right. And so I think there's, there's a problem here. I think the government's response.
- [24:17]
Caroline Hyde
Can you name the companies? Like, are there any secondary market providers, providers you take issue with in particular? Sorry, just briefly.
- [24:23]
IBM Representative
Name names. No, I mean, look like the, the reality is it's mostly individual bad actors. Very few of these, you know, second market brokerages or listing things are inherently the problem. The issue is investors, you know, not even investors, these brokers misrepresenting what they have access to. And that's not good in a public market, it's not good in a private market.
- [24:45]
Ed Ludlow
Noted.
- [24:46]
IBM Representative
So the, you know, I think it is a problem, problem, but you know, it's something that we do everything we can to control and try to help curtail and it's affecting every one of the companies are, you know, interesting in the private markets.
- [24:58]
Ed Ludlow
Brian, you've been generous to your time before we we lose you from the program. The President's visit to China, the timeline of the threat to Taiwan, 2027. What's Andrew's thinking on that?
- [25:11]
IBM Representative
Look, diplomacy is good. We are in the deterrence business. We do not want there to be conflict. And I think the President going and engaging with Xi is a fant fantastic thing and I'm very excited to see what comes out of this. And you know, we're also providing a lot of technology to Taiwan, supporting them in every opportunity we can because we believe that they need the right capabilities and to have the right deterrence. And you know, the long talked about window of 2027, kind of the period of maximum danger, I think it is true. You know, I don't think anyone believes that it was A, you know, January 1, 2027, an invasion begins, but it highlights a period where, you know, kind of the, the PRC has more established military capability and the US and Taiwan at a relative disadvantage compared to other points in time. And so it is a period of significant risk. And with all of the complexities going on in the world with Iran, with Ukraine, you know, with all the other areas that are, you know, hotspots in the world, it creates a significant stress on the US military. So I think this is the opportunity for diplomacy is good to try to ensure that nothing does happen and try to find a scenario that preserves the status quo that is working reasonably well. And that's, that's honestly what I hope for out of this summit.
- [26:36]
Caroline Hyde
Brian Schmf Fascinating. All things geopolitics, politics, all things to a raise $61 billion valuation. The Andrew CEO we so appreciate your time today. Look, it's expected to be the final day of evidence in the closely watched trial between elon Musk and OpenAI. Yesterday Sam Altman told jurors he was quote, extremely uncomfortable with Musk's insistence on having full control of the startup in its early days. Musk, you'll remember, is suing OpenAI, his former co founders and Microsoft, alleging that they abandoned the ChatGPT makers, his altruistic mission. Let's get more Bloomberg's editor Seth Figman. So what seems to have transpired or what's being articulated by Sam Altman is that at some point Elon Musk actually was thinking about a profit side of it, thinking about trying to earn control and indeed was then thinking of bequeathing it to his children if he died
- [27:25]
Seth Figman
Right as one does. Yeah, a little bit of a dramatic testimony there. So much of opening ise counter argument to my Musk claims here is that really his frustration is that he was not able to control and be CEO of OpenAI and the way that he is with all his other ventures. And so Sam Altman recounted a conversation with Musk where he allegedly said that, you know, if and when he were to die and he was in control of opening eye, he would pass it along to his children. Now you know that's opening I saying it. But Altman also said that, you know, Musk wanted control control in the early days, but wasn't really willing to sign documentation saying that control would lift at some point. In his own testimony, Musk has said, yeah, he might have had control early on, but the expectation was more investors would come in and eventually he wouldn't have that same level of control.
- [28:11]
Caroline Hyde
Bloomberg Stuff Figureman we so appreciate the roundup. We have some breaking news though that we must hit because crossing the terminal right now, AAM and its majority owner Softbank reportedly tried to buy Cerebras in an evenly split cash and stock deal that would have valued the upstart at 00 billion. According to sources, this all happened weeks before the chip maker was due to make its public debut. Of course, the person who's been busy breaking that story and also co anchoring the show on air is one Ed Ludlow. Talk us through it as to this was happening in the background during May.
- [28:45]
Ed Ludlow
Yeah look Cerebrus is going to is going to live tomorrow, right. And this happened at the beginning of May. They very clearly said no we're not interested. But Almond Softbank, which majority owns arm tried why? Very interesting. We can get into it in the back half of the show because there's a lot more to come on Bloomberg Tech. Welcome back to Bloomberg Tech. Let's get back to that news that broke just a few moments ago. ALM and its majority owner Super Softbank tried to buy Cerebras. That's according to sources. My understanding is this all happened in the last couple of weeks early May and it's just before Cerebras the chip maker is due to go public Thursday. They were rebuffed. You know Cerebra said no. My understand is understanding is Armitage bank would have happily paid a premium, big premium. But Cerebras backs itself and its its leadership back itself backs them and the investors back them. To do this alone as a public
- [29:43]
Caroline Hyde
company, I mean look at the demand for its IPO looks can be pricing today we understand it's going to price at the top end of the marketed range up to $160 plus. We're seeing maybe the biggest amount raised in a semiconductor name since ARM went public. Maybe even more of the green shoe allotment is used. But why would ALM and Cerebras have been sort of a useful synergy here?
- [30:03]
Ed Ludlow
Well because you know, ARM goes from being a chip designer to wanting to be a chip maker like actually sell directly into the market and Cerebras in this, in this phase of inference and I the broader infrastructure play it backs itself as well. Anyway, I should just probably note that all of the parties involved declined to comment or did not immediately respond to comment to Bloomberg. We should check in on markets because markets being driven by what's happening in Beijing. The NASDAQ 100 modestly higher 410 of a percent US listed Chinese companies. That's the Golden Dragon China index up 4%. A big part of this is Nvidia. Shares of Chinese AI model developers in particular surged after Nvidia CEO Jensen Huang was announced to be joining President Trump's China trip. Shares of Minimax and GPU on the hopes of progress on Nvidia's ability to sell chips into China. Look at those gains, gains overnight. Bloomberg's Chinese equities reporter Henry Ren is with us. Henry, look at those gains overnight. I mean the response in Asia trading was interesting.
- [31:05]
Henry Ren
Yeah, that's right. So the last minute trip by Jensen Huang is boosting the morale of mainland traders. We're seeing double digit gains in the likes of Drupal and Minimax as well the Chinese automakers, but not limited to that, that has obviously spread to today's US trading session as well. We see Alibaba jd the likes of those Chinese tech names also trading higher. In mainland session we have the Chinex index which is China's equivalent of NASDAQ for those young tech companies also soaring to a record. So there are some optimism that China and US could strike some form of deals on chip exports. And remember that Nvidia has gained approval from Washington to sell H2 High 400 chips into China since end of last year. But still there are some hopes that for more powerful models can be used.
- [31:57]
Caroline Hyde
Really interesting that you bring up Alibaba because actually Alibaba Tencent, they gave us fundamentals as well. They came out with their earnings and thus far they're investing a ton. But the return on that investment from AI investment just doesn't seem to be there yet.
- [32:12]
Henry Ren
Yeah, that's the huge issue. Issue that the market is focusing on today was both company reporting results. So probably we can start from Alibaba. So the company, I think it does reassure investors because it said its cloud revenue grew by about 40% in the first quarter and that's the key number that market is being has been focusing on. That's an acceleration from the quarter earlier. So it does show that there are some trajectory going on. And in a meaningful meantime it's also saying that for its AI related revenue related to its models as well as application services, that will reach about 110 billion RMB for the June quarter. So that's a helpful additional disclosure as well. So it does show some momentum but at the same time that capex has been soaring as you mentioned.
- [33:02]
Caroline Hyde
Yeah, yeah. Meanwhile Tencent remains reported the slowest pace of revenue growth in over a year. Henry Ren, it's always great to catch up with you and the latest on all things China and AI. But now let's take a look at today's big number. It's around AI and it's over $900 billion. This is anthropic's targeted new valuation according to sources who say the company is in early talks with investors to raise at least $30 billion in fresh financing. It could set the stage for what may be the largest funding round yet for the company. Though the deal, deal, it's not been finalized. No term sheet has been signed. Natasha Mascara and joins us now, who helped break this story alongside Ed. And just tell us a little bit about the inbounds, almost the love letters they've been receiving from potential investors.
- [33:44]
Natasha Mascarenas
It's a great way to describe it, Caroline. I mean a few weeks ago these were conversations that were coming completely unsolicited from Anthropic backers. Now we have reporting that they are engaging in those conversations and discussing around that could see them raise at least 30 billion. And sources are telling us that the round could close as soon as the end of this month. It's one that we're tracking very closely and definitely the biggest update we've had on the round throughout this circus of interest.
- [34:13]
Ed Ludlow
You know, the private markets are alive, you know, to put it mildly. And it's interesting this hashtag, you know, Anthropic feels comfortable now with this valuation here we've got from a place in just the last two or three weeks where they rebuffed office and now, you know, we don't want to do this. But the main thing that's happened in the interim is that Claude continues to have momentum enterprise adoption of Anthropic. And then there's the mephos government angle. Give us the sort of awkward elephant in the room, which is that if they close this round, they will have a valuation higher than open air.
- [34:47]
Natasha Mascarenas
Absolutely. I mean, this is is a massive narrative shift around Anthropic, and we've been covering it relentlessly. Our understanding is that the investor interest far exceeds how much Anthropic will actually end up accepting from investors. And so you are seeing them maybe be picky on valuation. Lead investor. The term sheet is not officially signed as of our reporting last evening, but we do expect that to change, you know, as fast as we're able to confirm it. And so, so the real question and what we're looking at next is let's say Anthropic closes this round as per our sources, as soon as the end of this month. Does this change their IPO timeline? Does it need to change their IPO timeline? I mean, you guys just had Brian Chimp from Andrew on the show who is saying that Anduril is raising just a quarter of what AI financing is. I'm curious what you think, Ed, about if this does, you know, change when we see the S1 officially filed for an Anthropo.
- [35:40]
Ed Ludlow
Well, it depends what happens with Space X June, July. Does that suck oxygen out of the room? But again, if the private markets provide, what's the need to go public? Bloomberg's Natasha Mascarenas teaming up on another big twist and turn in the Anthropic story.
- [35:56]
Caroline Hyde
Some breaking news regarding Mistral. The giant of France is apparently developing a new AI model for banks who lack access to Mythos. This is all about cybersecurity vulnerabilities. Already, Mistral of France had been working with local European banks to have a new model that would stress test cyber risks around the banks and more broadly in their systems. Well, now we understand those banks, of course, have been wanting access to Mythos. And now Mistral is looking to develop this new model that can uncover cybersecurity vulnerabilities at unprecedented speed and scale.
- [36:29]
Ed Ludlow
At that reporting, all according to Bloomberg, Bloomberg sources. Okay, Varda Space is planning to send medicines from United Therapeutics into orbit to explore the use of microgravity in creating drugs. It's one of the first commercial research deals to develop medicine molecules in space and then return them to Earth. Though the mission is still in its early stages, I speak with Auto CEO Will Brewery. Let's talk timeline. This is an exciting development for you guys because it's a real commercial opportunity. When does it happen? What are the steps to start working with United?
- [36:59]
Will Bruey
Yeah, thanks for having me, Ed. It's happening now, which is really exciting. The research has been done for decades and so now we're moving into the commercial phase. Varda has been flying for years, and so this commercial endeavor will be putting drugs into space in the next year. We're working on those drugs right now in the lab with United.
- [37:14]
Caroline Hyde
And when they're in space, what are you hoping to prove? What are you hoping to see? Where does this drive United?
- [37:20]
Will Bruey
So the most confusing thing about Varda is the space park. If you just imagine we had an anti gravity technology, admit it.
- [37:25]
Henry Ren
Yeah.
- [37:26]
Will Bruey
If you, if you imagine we had an anti gravity technology where we could manipulate chemical systems on Earth to improve formulations in a way that would otherwise be impossible. And by formulation I mean going from like an IV bag to a shot or better, better bioavailability then it would make total sense. Now, as shipping to space is becoming just shipping, we can access microgravity in a way that helps patients.
- [37:45]
Ed Ludlow
Today I've had the opportunity to sort of interact with, act with, I don't know, you call it a spacecraft or if you call it a mini factory, but just go through the basics of who's the launch provider, what happens when you get into low Earth orbit and then how long typically is the spacecraft or capsule in orbit.
- [38:02]
IBM Representative
Sure.
- [38:03]
Will Bruey
So I'll even step back just because we're so excited about this United announcement today. First we work with the customers before we even get there and we develop a microgravity enabled formulation on the ground in our lab in cooperation and partnership with United. Once those microgravity enabled formulations are ready
- [38:18]
Caroline Hyde
for flight, what does that look like, microgravity enabled formula?
- [38:21]
Will Bruey
It means that the temperature profile, the concentration, all the parameters that would go into any other drug formulation now has the option of turning off gravity during the process, which means we can make a new outcome for patients. So then what we do is once we have that formulation, we load it into our spacecraft. Our launch provider is SpaceX. We launch, put our spacecraft on onto a Falcon 9 rocket.
- [38:41]
Ed Ludlow
Dedicated or rideshare.
- [38:43]
Will Bruey
Rideshare, which is great because now we get to take advantage of good costs and frequent availability to space. So now the spacecraft separates from the rocket like it would any other satellite. So it looks like a satellite to Space X. You can fit 20 of these things on a single rocket. It's now orbiting the Earth. We do the manufacturing process where there isn't gravity affecting the sedimentation of the crystals. And then once those properties are locked in, our spacecraft flies itself back to Earth. Earth lands in Australia and Now we have the drug for patients.
- [39:09]
Caroline Hyde
And what does it help patients with? I mean, how is this going to unleash a whole new area of medicine?
- [39:15]
Will Bruey
It's wild because it's. Gravity is a fundamental force of physics. So it's extremely broad technology. Anything from bioavailability to shelf stability. A classic example that was flown on the International Space Station was going from an IV bag to a shot. So imagine you're in rural America and you don't have access to a clinic. You now have access to access to the drug because that same drug can be form factored into a shot instead of an IV bag. And that shot can come to you instead of you having to go to the clinic.
- [39:39]
Ed Ludlow
We're showing images, right? This is images of Vada returning to Earth. So. So this sounds ridiculous and I'll say it anyway. You try and land in Australia. That seems quite easy. Australia is quite big, actually. It's not like how restrictive is that, that landing pad of one continental nation?
- [39:58]
Will Bruey
Yes, yes. So more than try. I mean, we've done this now four or five times. And the reason I say four or five, one of them was in Utah and the rest were in Australia.
- [40:05]
Ed Ludlow
How'd that go in Utah?
- [40:07]
Will Bruey
Oh, it was great. I mean, you know, mission. That was our first mission success.
- [40:10]
IBM Representative
Yeah.
- [40:11]
Will Bruey
The thing that's nice about Australia is it's a commercial range, so we don't need to get in the way of, of the military operations that are happening at our test ranges. So we can not disturb them while, while landing commercially. But it's great. I mean, it's, it makes, makes the, the, the process way easier.
- [40:28]
Caroline Hyde
You're excited about United Therapeutics deal. Where next? How what does this prove out for others?
- [40:33]
Will Bruey
Well, this is just the tip of the tip of the iceberg because it's such a broad technology that affects so many drugs. You know, United is kind of in the future and they have been for quite some time, and so we're really lucky to work with such a crack team. But this technology is broad, so it's, it applies to a wide variety of pharmaceuticals for a wide variety of patients.
- [40:54]
Caroline Hyde
Well, as that starts to go up into space, come back, join us. Will vary CEO of VARDA Space on that new announcement. Meanwhile, there's been plenty of announcements coming out about agentic commerce and international expansion from a firm it's just been reporting yesterday at the company's 2026 investor forum, the Fintech company is laying out a bold roadmap to $100 billion in assets annual volume. Look, CEO Max Levchin, I'm pleased to say, joins us in New York. And I'm sad I'm not there next to you, Max, but tell us about what your. I know, I know too far, but I'm interested in what you told the investors, the analyst community in New York yesterday and for the next few days. How do you get to that sort of volume? Where are the growth factors?
- [41:35]
Max Levchin
You know, the exciting thing is that literally everything we have been working towards is coming together and working incredibly well. We held a similar event three years ago and promised investors we'll get to $50 billion of gross merchandise volume, our merchant sales that we power. And we will do so by maintaining, while maintaining our profit margins. In 3 and 4% we will grow at 20% per year or so. That was the story we told them three years ago. We've now come back. We are now basically at that $50 billion mark. You would expect us to slow down, but instead we told our investor base yesterday we expect to grow 25% compounding so 5 points extra and we intend to up the floor of our profitability from 3 to 3.75%. So not only are we growing faster, not only are we reaching more consumers, more merchants, we intend to do this more profitably and we feel it's, it's just getting better and better for us. So that, that's the, that's the headline and you know, a lot of conversations yesterday that seemed to indicate that our investors are quite enjoying the news.
- [42:36]
Ed Ludlow
Max, just very simply, why is a $100 billion volume target, the right target, the right metric? When people try and understand a firm like you come the show often and we talk about the different offerings and some of the newer products that you're doing this kind of North Star or achievable goal, probably to your mind, it's really interesting that you've set that as
- [42:55]
Max Levchin
it, you know, it is just a waypoint. We have absolutely no intention of slowing down or stopping at.100 is just another nice round number that we can us at our sights too. But we do see an incredible market pull. Consumers are ready. They are coming to us. We are now seeing inbounds from consumers that have didn't discover us at the point of sale, which is the usual way just signing up for a firm asking us to send them a card so they can transact everywhere. That's been a huge pull that's contributed to our growth tremendously. Merchants come to us saying, I've seen your logo on my competitors sites. I know you're driving 10, 20% more sales for the them. You should do the same for us. Let us sign up. You should promote our sales events Telus merchants in your app because we're now reaching 15 million monthly consumers and so on. So just the tremendous amount of we're finally a real scalable thing that every institution cares about a lot is what gives us the confidence to, to go towards this new milestone.
- [43:49]
Caroline Hyde
And analysts liked it like RBC talking about the pending industrial bank charter. That could be another strength area that, that the fact that you've got competitive advantage. But take us to the future and the agentic commerce future because we talk about it a lot on the show and you are already doing deals with Google. What does that look like in terms of how I'm going to be having a relationship with a firm going forward?
- [44:10]
Max Levchin
I think it's going to be incredible. I cannot be more excited about this new AI powered future in many different facets. As an engineer, as a, as a coder, I love what we have today. As a consumer, as a buyer of complicated things, I love the help that I provide me when I research the finer points of, you know, whatever it is that I'm after now. A firm is a great tool of buying things that are meaningful when it matters. That's when consumers come to us. They want anything from a bicycle to a couch to an espresso machine. During those moments you want to know that the financing choice you're making has your back, that you're not going to get hit with some unexpected expected fees. You know exactly when you're going to start and stop with your payments. That's what we've built and agents just make it that much easier to bring to the end consumer. And the brand we've built allows people to trust us. The fact that we're able to partner with LM providers allows us to be right there when consumers are searching and doing the research. So it's just an incredible incremental growth engine that we found.
- [45:10]
Ed Ludlow
Max, you're again emphasizing the word business built. You do that often. But how does quickly Max left Chin think about M and A in a firm's future?
- [45:18]
Max Levchin
You know, we've looked for years. We haven't found anything in the last few. So never say never. But we have so much to do just with the team that we have. It's, you know, when opportunities come up, we'll of course look at them, but we're very focused on building.
- [45:31]
Ed Ludlow
Affirm CEO Max Levchin back on Bloomberg Tech. Thank you very much for your time today. Now. Coming up, we're going to get bankruptcy to what to expect from President Trump's meeting with Xi Jinping and will I be in focus? Probably. This is Bloomberg Tech Coffee Genius here.
- [45:47]
Public Ad Representative
Most people see a busy cafe, but I see precision at every step thanks to Genius. From global payments transactions, instant inventory, precise operations in sync. Absolutely Genius. From sold out crowds worldwide to managing the morning rush, genius keeps operations running smoothly. One Portado Flawless pour, perfectly timed, just beautiful big league reliability for any business. That's genius. Support for the show comes from Public. Public is an investing platform that offers access to stocks, options, bonds and crypto, and they've also integrated AI with tools that can assist investors in building customized portfolios. One of these tools is called Generated Assets. It allows you to turn your ideas into investable indexes. So let's say you're interested in something specific like biotech companies with high R and D spend, small cap stocks with improving operating margins, or the S&P 500 minus high debt companies. Chances are there isn't an ETF that fits your exact criteria. But on Public you just type in a prompt and their AI screens thousands of stocks and builds a one of a kind index. You can even backtest it against the S&P 500. Then you can invest in a few clicks, go to public.com market and earn an uncapped 1% bonus when you transfer your portfolio. That's public.com market ad paid for by Public Holdings Brokerage Services by Public Investing member finra SIPC Advisory Services by Public Advisors SEC Registered Advisor crypto services by ZeroHash sample prompts are for illustrative purposes only, not investment advice. All investing involves risk of loss. See complete disclosures@public.com disclosures small businesses are
- [47:29]
Cincinnati Insurance Narrator
the pulse of every community. They bring people together, create opportunities and drive growth. With a widespread presence in communities across the country, Chase for Business supports small business owners at a local level that makes it possible for you to connect, learn from each other and grow together. There's a real commitment to seeing small businesses succeed. The Chase for Business team has knowledge and expertise that span a wide range of financial areas. They can help you make more informed decisions as you navigate the complexities of running your business. They'll help your business grow with individual guidance and convenient digital tools all in one place. With that guidance and your determination, you can take your business farther and help build a brighter future for your community. Learn more@chase.com business chase for business make more of what's Yours the Chase Mobile app is available for select mobile devices, message and data rates may apply. JPMorgan Chase Bank NA Member FDIC Member Copyright 2026 JPMorgan Chase Co.
- [48:30]
Caroline Hyde
It's time now for Talking Tech. And first up, SoftBank posted a jump in profit fueled by valuation gains on its open air investment. Founder Master She San has spent the last year pivoting the company's focus from venture startups to silicon and data centers. Plus, following a visit from Scott Bessant, Japan's three mega banks are set to gain access to Anthropic's powerful, powerful Mythos model. According to the person many with the matter now. The move comes despite a widespread alarm over methods and speculation about its potential cybersecurity risks and nevs while it's emerging as a powerhouse in the data center. Gold rush reporting a 684% jump in first quarter sales on increased demand for its own data centers, the company competes with a range of neo cloud startups like Core Weave that rent out computing resources to AI developers.
- [49:15]
Ed Ludlow
Ed okay, let's get back to what everyone's talking about today and that's President Trump's meeting with Xi Jinping and what to expect. Bloomberg's senior tech editor Mike shepherd joins us from dc. Go to our senior tech editor because there is a big delegation of tech CEOs with the President. Jensen Huang is with him and those are the issues on the table.
- [49:35]
Mike Shepherd
Those are and you know, the addition at the last minute and a really dramatic move of Jensen Huang to the trip certainly thrust artificial intelligence to the center of the discussions. It's unclear what sort of progress we will actually see in the areas that are most dear to Nvidia and that would be gaining more access to the Chinese market. They have won us permission to sell those H200AI chips to customers in China. But Chinese authorities have been reluctant to allow their own producers to buy those chips en masse. And the reason is they want want to promote and protect their own domestic chipmaking industry led by Huawei, led by Camera Khan and Smic. And yet there is the tension on the other side. They want their own artificial intelligence companies, the model developers also to gain an edge and they have been clamoring for that. And today we did see shares of Mini Max Knowledge, Atlas and even today US traded shares of Alibaba and Baidu. All clients time on the prospect that there could be more compute going to China.
- [50:39]
Caroline Hyde
Talk to us about the names that were already solidified as going because Qualcomm's going, Micron's going companies with exposure to China that want to increase. Where would they be fitting in to the ultimate demand equation here?
- [50:52]
Mike Shepherd
Well, the broader demand equation, of course for Micron. They have their own separate issues with China where they are almost company not on Grada at a certain level. Their role in the memory market is really key as well. And it's something that for chip makers and developers worldwide, they want to have a piece of being able to contribute to the creation of AI processors not only designed by Nvidia and by amd, but by other companies as well. So they could be looking to push into there. And same with Qualcomm. Qualcomm of course has a lot of of business when it comes to chips for mobile phones and that could be a way in there more broadly. When we look at this trip in its agenda though, Carol, it's interesting that we see the White House science and technology policy adviser Michael Kratzio is there and this could signal that AI and discussions around the technology will be really front and center. We could see the US Raise concerns about the practice of distillation that we have seen seen where AI models are unfairly extracted and and also a working group created to discuss AI.
- [52:00]
Caroline Hyde
Mike Shepard, across all the latest coming between those key talks in Beijing at the moment. We appreciate you rounding it up, but that does it for this edition of Bloomberg Tech right here from San Francisco. We've got to get back to that breaking news that you helped break Ed, earlier this hour. Talk us through why ARM was potentially looking to buy cerebras.
- [52:18]
Ed Ludlow
Yeah, ARM and SoftBank tried to buy Cerebra. Cerebra said no, they will go public tomorrow. But Cerebras makes supercomputers at scale for inference and that's where the story is right now. That of course, all according to Bloomberg sources. Recap that story and many others on the podcast. You know where to find it. Apple, Spotify, Iheart and all of the Bloomberg platforms. This is Bloomberg Tech.
- [52:40]
Public Ad Representative
When you're running a business, the best days are the ones where priorities stay on track.
- [52:44]
Caroline Hyde
Risk.
- [52:44]
Public Ad Representative
For midsize and large companies, risk can affect multiple parts of the organization at once, from property and liability to cyber and regulatory challenges. At that level, managing risk becomes an ongoing discipline. At the Hartford, the focus is on helping businesses manage risk before it turns into something more disruptive. And when losses do happen, that work is paired with insurance coverage shaped by years of underwriting, risk engineering and claims experience. Learn more@thehartford.com riskmitigation policies provided by Hartford Fire Insurance Company and its property and casualty affiliates. Hartford Connecticut these days it seems like
- [53:21]
Will Bruey
AI agents are just about everywhere you turn every field and every function.
- [53:25]
Public Ad Representative
But without identity, you can't trust they'll serve your business instead of jeopardizing it. Fortunately, Okta helps you get identity right
- [53:33]
IBM Representative
by securing your AI agents identities, giving you a single layer of control, a
- [53:38]
Public Ad Representative
single standard of trust. So whether an AI agent supports a
- [53:41]
IBM Representative
single user or your entire enterprise, with
- [53:44]
Public Ad Representative
Okta you'll turn risk into opportunity. Secure every agent, secure any agent. Okta secures AI it's 10:01am on a Monday all at once. Your sales leader needs to know which deals are at risk, your PM wants feature adoption by cohort and your CFO needs one last graph for the board. Now your data team has to say no to somebody. Hex changes that. Ask any data question in plain English and get an analyst grade response all backed by your actual business context as defined by your data team. Start saying yes to more data questions at Hex AI.